Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
28.2M
-
Shares change
-
+1.63M
-
Total reported value, excl. options
-
$235M
-
Value change
-
+$16.4M
-
Number of buys
-
59
-
Number of sells
-
-39
-
Price
-
$8.33
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2021
109 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q2 2021.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.2M shares
of 44.7M outstanding shares and own 63.16% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.73M shares), ROYCE & ASSOCIATES LP (2.01M shares), DIMENSIONAL FUND ADVISORS LP (1.96M shares), VANGUARD GROUP INC (1.93M shares), Portolan Capital Management, LLC (1.82M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (1.67M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.54M shares), RENAISSANCE TECHNOLOGIES LLC (1.23M shares), Harvey Partners, LLC (1.1M shares), and ACADIAN ASSET MANAGEMENT LLC (1.08M shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.